Navigation Links
Gardasil, a cervical cancer vaccine, hits the market

This is indeed an important milestone in the development of strategies to combat cervical abnormalities; the worlds first ever vaccine for cervical cancer, named Gardasil, has// made it to the market.

A feather in the cap of Professor Frazer, a scientist in Queens land and the brain behind this vaccine, who has relentlessly worked on this working on it since 1990, is all set to administer the inaugural shot. This vaccine is powerful in containing the spread of sexually transmitted human papilloma virus (HPV), the main reason behind cervical cancer. Further this vaccine will also protect against HPV, which causes genital warts.

An ecstatic Fraser said 'The vaccine will be available from today so if someone turns up at the pharmacy with a script they'll be able to get it. I know there's a large number of people waiting for this particular day to happen because I get phoned up regularly and asked when it was going to occur.'

The Therapeutic Goods Administration (TGA) has permitted the use of this vaccine for boys aged nine to 15 and girls aged nine to 26. This vaccine holds a world of promise, based on the results of the clinical trials, where nearly 20,000 women received 100% protection from cervical cancer and 99% insulation from genital warts.
'"/>




Page: 1

Related medicine news :

1. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
2. Virus connection to cervical injury
3. Test for prenatal chromosomal abnormalities using cervical swab
4. Two New Human Papilloma virus (HPV) vaccines to prevent cervical cancer
5. Gardasil vaccine for cervical cancer
6. Two screen test and treat screening for cervical cancer
7. Religious groups overcome objections to cervical cancer vaccines
8. Merck, ICMR to conduct joint trials on cervical cancer vaccine
9. Economic and Ethical disparities hinder cervical cancer screening
10. Conventional pap smears techniques to detect cervical cancer are here to stay
11. The need to revamp cervical cancer prevention programs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may be commonplace ... injury, it occurs when the muscles around the pelvis become inflamed. Over time, ... lower torso, as well as accompanying tenderness and weakness. Without proper intervention, it ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... simulation -centric training, today announced the launch of a new research study, The ... the skills needed to execute that strategy, and the actual success of achieving ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... announce that for a second year in a row; they are the recipient ... designers in the industry voted on the award at Design Connections 2017. Top ...
(Date:3/27/2017)... CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still in shock ... the best days I’ve had in a long time,” she said. , She thinks the ... of money that I never thought I would have to help my students.” , The ...
(Date:3/27/2017)... ... ... The Anaheim Hills office accelerates and supports FNCC’s growth and further strengthens ... professionals over the past 6 months and is continuing to recruit new talent with ... of 2017. , “This new office is a direct result of our strong ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
(Date:3/27/2017)... Texas , March 27, 2017   Genprex, Inc. , ... that Julien Pham , MD, the Company,s Chief Operating Officer, ... investor conferences. Sachs 5th Annual Cancer BioPartnering & ... New York, NY ... BioCentury 24th Annual Future Leaders in ...
(Date:3/24/2017)... PUNE, India , March 24, 2017 ... Stimulators Market: Global Opportunity Analysis and Industry Forecast, 2014-2022," the spine bone stimulators ... $724 million by 2022, growing at a CAGR of 3.6% during the forecast ... ... Allied Market Research Logo ...
Breaking Medicine Technology: